Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial

Background: Female patients who undergo gynecological laparoscopic surgery are more likely to suffer from postoperative nausea and vomiting (PONV). The study aimed to probe and investigate the effectiveness of intraperitoneal administration of dexamethasone, dexmedetomidine, and combination in reduc...

Full description

Bibliographic Details
Main Authors: Vinit Kumar Srivastava, Pooja Shree, Sanjay Agrawal, Ambikesh Pandey, Kavita Babbar, Kumari Manju
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Bali Journal of Anesthesiology
Subjects:
Online Access:http://www.bjoaonline.com/article.asp?issn=2549-2276;year=2022;volume=6;issue=4;spage=225;epage=230;aulast=Srivastava
_version_ 1811220600350310400
author Vinit Kumar Srivastava
Pooja Shree
Sanjay Agrawal
Ambikesh Pandey
Kavita Babbar
Kumari Manju
author_facet Vinit Kumar Srivastava
Pooja Shree
Sanjay Agrawal
Ambikesh Pandey
Kavita Babbar
Kumari Manju
author_sort Vinit Kumar Srivastava
collection DOAJ
description Background: Female patients who undergo gynecological laparoscopic surgery are more likely to suffer from postoperative nausea and vomiting (PONV). The study aimed to probe and investigate the effectiveness of intraperitoneal administration of dexamethasone, dexmedetomidine, and combination in reducing the incidence of PONV and postoperative analgesic requirements in laparoscopic hysterectomies. Materials and Methods: One hundred ninety-two female patients undergoing laparoscopic hysterectomies were randomly assigned to four groups. Anesthesia was identical in each group. Patients in the group D1 received dexamethasone 8 mg, group D2 received dexmedetomidine 1 μg/kg, group D3 received dexamethasone 8 mg + dexmedetomidine 1 μg/kg combination, and group D4 received 20 mL normal saline intraperitoneally at the end of the surgery, before trocar removal. The primary outcome was the incidence of PONV experienced by the patients within 24-h postoperative period. Results: In the first 24 h postoperatively, the incidence of PONV was significantly reduced in D1, D2, and D3 groups compared with D4 (P = 0.001); however, there were no significant differences among the three groups. The requirement for rescue antiemetic and rescue analgesic was similar among the groups but significantly decreased compared with the control group (group D4) (P = 0.002 and P = 0.0003, respectively). Conclusion: Intraperitoneal administration of dexamethasone, dexmedetomidine, and a combination of dexamethasone–dexmedetomidine in laparoscopic hysterectomies significantly reduces both PONV and postoperative analgesics requirements compared with the control group.
first_indexed 2024-04-12T07:45:55Z
format Article
id doaj.art-75528c96ea4d4e44ae016b1fd5a64303
institution Directory Open Access Journal
issn 2549-2276
language English
last_indexed 2024-04-12T07:45:55Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Bali Journal of Anesthesiology
spelling doaj.art-75528c96ea4d4e44ae016b1fd5a643032022-12-22T03:41:43ZengWolters Kluwer Medknow PublicationsBali Journal of Anesthesiology2549-22762022-01-016422523010.4103/bjoa.bjoa_202_22Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trialVinit Kumar SrivastavaPooja ShreeSanjay AgrawalAmbikesh PandeyKavita BabbarKumari ManjuBackground: Female patients who undergo gynecological laparoscopic surgery are more likely to suffer from postoperative nausea and vomiting (PONV). The study aimed to probe and investigate the effectiveness of intraperitoneal administration of dexamethasone, dexmedetomidine, and combination in reducing the incidence of PONV and postoperative analgesic requirements in laparoscopic hysterectomies. Materials and Methods: One hundred ninety-two female patients undergoing laparoscopic hysterectomies were randomly assigned to four groups. Anesthesia was identical in each group. Patients in the group D1 received dexamethasone 8 mg, group D2 received dexmedetomidine 1 μg/kg, group D3 received dexamethasone 8 mg + dexmedetomidine 1 μg/kg combination, and group D4 received 20 mL normal saline intraperitoneally at the end of the surgery, before trocar removal. The primary outcome was the incidence of PONV experienced by the patients within 24-h postoperative period. Results: In the first 24 h postoperatively, the incidence of PONV was significantly reduced in D1, D2, and D3 groups compared with D4 (P = 0.001); however, there were no significant differences among the three groups. The requirement for rescue antiemetic and rescue analgesic was similar among the groups but significantly decreased compared with the control group (group D4) (P = 0.002 and P = 0.0003, respectively). Conclusion: Intraperitoneal administration of dexamethasone, dexmedetomidine, and a combination of dexamethasone–dexmedetomidine in laparoscopic hysterectomies significantly reduces both PONV and postoperative analgesics requirements compared with the control group.http://www.bjoaonline.com/article.asp?issn=2549-2276;year=2022;volume=6;issue=4;spage=225;epage=230;aulast=Srivastavadexamethasonedexmedetomidineintraperitoneallaparoscopic hysterectomypostoperative nausea and vomiting
spellingShingle Vinit Kumar Srivastava
Pooja Shree
Sanjay Agrawal
Ambikesh Pandey
Kavita Babbar
Kumari Manju
Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
Bali Journal of Anesthesiology
dexamethasone
dexmedetomidine
intraperitoneal
laparoscopic hysterectomy
postoperative nausea and vomiting
title Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
title_full Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
title_fullStr Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
title_full_unstemmed Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
title_short Comparison of intraperitoneal dexamethasone, dexmedetomidine, and dexamethasone–dexmedetomidine combination on postoperative nausea, vomiting, and analgesics requirement after gynecological laparoscopy: A randomized clinical trial
title_sort comparison of intraperitoneal dexamethasone dexmedetomidine and dexamethasone dexmedetomidine combination on postoperative nausea vomiting and analgesics requirement after gynecological laparoscopy a randomized clinical trial
topic dexamethasone
dexmedetomidine
intraperitoneal
laparoscopic hysterectomy
postoperative nausea and vomiting
url http://www.bjoaonline.com/article.asp?issn=2549-2276;year=2022;volume=6;issue=4;spage=225;epage=230;aulast=Srivastava
work_keys_str_mv AT vinitkumarsrivastava comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial
AT poojashree comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial
AT sanjayagrawal comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial
AT ambikeshpandey comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial
AT kavitababbar comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial
AT kumarimanju comparisonofintraperitonealdexamethasonedexmedetomidineanddexamethasonedexmedetomidinecombinationonpostoperativenauseavomitingandanalgesicsrequirementaftergynecologicallaparoscopyarandomizedclinicaltrial